Q3 2016 EPS Estimates for Acadia Healthcare Co. (ACHC) Decreased by Analyst
Acadia Healthcare Co. (NASDAQ:ACHC) – Analysts at KeyCorp lowered their Q3 2016 earnings estimates for Acadia Healthcare in a note issued to investors on Monday. KeyCorp analyst J. Gurda now forecasts that the brokerage will earn $0.66 per share for the quarter, down from their prior forecast of $0.68. KeyCorp also issued estimates for Acadia Healthcare’s FY2016 earnings at $2.57 EPS, FY2017 earnings at $3.06 EPS and FY2018 earnings at $3.79 EPS.
Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Friday, July 29th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. The company had revenue of $756.50 million for the quarter, compared to the consensus estimate of $752.57 million. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. The company’s quarterly revenue was up 66.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.57 earnings per share.
A number of other research firms have also recently issued reports on ACHC. Leerink Swann reiterated a “buy” rating and set a $80.00 target price on shares of Acadia Healthcare in a report on Sunday, August 28th. Jefferies Group restated a “buy” rating and set a $85.00 price objective on shares of Acadia Healthcare in a research note on Monday, June 27th. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, October 3rd. Royal Bank Of Canada reduced their price objective on shares of Acadia Healthcare from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Monday, August 1st. Finally, JPMorgan Chase & Co. restated a “hold” rating and set a $61.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, September 27th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $77.21.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/18/q3-2016-eps-estimates-for-acadia-healthcare-co-achc-decreased-by-analyst.html
Acadia Healthcare (NASDAQ:ACHC) traded up 1.77% during midday trading on Tuesday, reaching $44.21. The company’s stock had a trading volume of 321,648 shares. Acadia Healthcare has a 52 week low of $42.47 and a 52 week high of $74.77. The firm has a 50 day moving average price of $49.16 and a 200-day moving average price of $54.58. The firm has a market cap of $3.86 billion, a P/E ratio of 23.62 and a beta of 0.86.
A number of large investors have recently modified their holdings of the company. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 97.2% in the first quarter. Wellington Management Group LLP now owns 6,983,799 shares of the company’s stock valued at $384,877,000 after buying an additional 3,441,579 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Acadia Healthcare by 5.3% in the second quarter. JPMorgan Chase & Co. now owns 4,999,726 shares of the company’s stock valued at $276,985,000 after buying an additional 251,179 shares during the period. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 6.0% in the second quarter. Vanguard Group Inc. now owns 4,980,554 shares of the company’s stock valued at $275,924,000 after buying an additional 283,624 shares during the period. TCW Group Inc. increased its stake in shares of Acadia Healthcare by 32.2% in the second quarter. TCW Group Inc. now owns 1,828,660 shares of the company’s stock valued at $101,308,000 after buying an additional 445,200 shares during the period. Finally, BlackRock Institutional Trust Company N.A. increased its stake in shares of Acadia Healthcare by 10.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,824,171 shares of the company’s stock valued at $101,059,000 after buying an additional 166,706 shares during the period.
In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 8,800 shares of the firm’s stock in a transaction that occurred on Monday, August 8th. The shares were sold at an average price of $52.56, for a total transaction of $462,528.00. Following the completion of the sale, the chief operating officer now directly owns 120,780 shares in the company, valued at $6,348,196.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO David M. Duckworth sold 16,670 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $54.33, for a total transaction of $905,681.10. Following the sale, the chief financial officer now owns 11,688 shares of the company’s stock, valued at $635,009.04. The disclosure for this sale can be found here. Company insiders own 17.20% of the company’s stock.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.